APA (7th ed.) Citation

RJ, A., O, H., R, P., I, B., G, R., SF, W., . . . RH, F. (2024). Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia. The New England journal of medicine, 391(6), 504. https://doi.org/10.1056/NEJMoa2404656

Chicago Style (17th ed.) Citation

RJ, Auchus, et al. "Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia." The New England Journal of Medicine 391, no. 6 (2024): 504. https://doi.org/10.1056/NEJMoa2404656.

MLA (9th ed.) Citation

RJ, Auchus, et al. "Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia." The New England Journal of Medicine, vol. 391, no. 6, 2024, p. 504, https://doi.org/10.1056/NEJMoa2404656.